116 related articles for article (PubMed ID: 34395761)
21. A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.
Meuleman P; Catanese MT; Verhoye L; Desombere I; Farhoudi A; Jones CT; Sheahan T; Grzyb K; Cortese R; Rice CM; Leroux-Roels G; Nicosia A
Hepatology; 2012 Feb; 55(2):364-72. PubMed ID: 21953761
[TBL] [Abstract][Full Text] [Related]
22. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A
mBio; 2016 Nov; 7(6):. PubMed ID: 27834208
[TBL] [Abstract][Full Text] [Related]
23. Testing of corneoscleral discs and their culture media of seropositive donors for hepatitis B and C virus genomes.
Sengler U; Reinhard T; Adams O; Gerlich W; Sundmacher R
Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):783-7. PubMed ID: 11760041
[TBL] [Abstract][Full Text] [Related]
24. Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2.
Colbert MD; Flyak AI; Ogega CO; Kinchen VJ; Massaccesi G; Hernandez M; Davidson E; Doranz BJ; Cox AL; Crowe JE; Bailey JR
J Virol; 2019 Jul; 93(14):. PubMed ID: 31068427
[TBL] [Abstract][Full Text] [Related]
25. A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.
Urbanowicz RA; McClure CP; Brown RJ; Tsoleridis T; Persson MA; Krey T; Irving WL; Ball JK; Tarr AW
J Virol; 2015 Dec; 90(7):3288-301. PubMed ID: 26699643
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
[TBL] [Abstract][Full Text] [Related]
27. Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp).
Bailey JR; Urbanowicz RA; Ball JK; Law M; Foung SKH
Methods Mol Biol; 2019; 1911():441-450. PubMed ID: 30593644
[TBL] [Abstract][Full Text] [Related]
28. Image-based Quantification of Direct Cell-to-cell Transmission of Bovine Viral Diarrhea Virus.
Merwaiss F; Alvarez DE
Bio Protoc; 2019 Aug; 9(15):e3319. PubMed ID: 33654826
[TBL] [Abstract][Full Text] [Related]
29. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
Chmielewska AM; Naddeo M; Capone S; Ammendola V; Hu K; Meredith L; Verhoye L; Rychlowska M; Rappuoli R; Ulmer JB; Colloca S; Nicosia A; Cortese R; Leroux-Roels G; Balfe P; Bienkowska-Szewczyk K; Meuleman P; McKeating JA; Folgori A
J Virol; 2014 May; 88(10):5502-10. PubMed ID: 24599994
[TBL] [Abstract][Full Text] [Related]
30. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
Bose M; Mullick R; Das S; Das S; Karande AA
Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies.
Timpe JM; Stamataki Z; Jennings A; Hu K; Farquhar MJ; Harris HJ; Schwarz A; Desombere I; Roels GL; Balfe P; McKeating JA
Hepatology; 2008 Jan; 47(1):17-24. PubMed ID: 17941058
[TBL] [Abstract][Full Text] [Related]
32. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
33. Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.
Laidlaw SM; Marukian S; Gilmore RH; Cashman SB; Nechyporuk-Zloy V; Rice CM; Dustin LB
Gastroenterology; 2017 Aug; 153(2):566-578.e5. PubMed ID: 28456632
[TBL] [Abstract][Full Text] [Related]
34. Delineating morbillivirus entry, dissemination and airborne transmission by studying in vivo competition of multicolor canine distemper viruses in ferrets.
de Vries RD; Ludlow M; de Jong A; Rennick LJ; Verburgh RJ; van Amerongen G; van Riel D; van Run PRWA; Herfst S; Kuiken T; Fouchier RAM; Osterhaus ADME; de Swart RL; Duprex WP
PLoS Pathog; 2017 May; 13(5):e1006371. PubMed ID: 28481926
[TBL] [Abstract][Full Text] [Related]
35. High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals.
Pihl AF; Offersgaard AF; Mathiesen CK; Prentoe J; Fahnøe U; Krarup H; Bukh J; Gottwein JM
Sci Rep; 2018 Nov; 8(1):17505. PubMed ID: 30504788
[TBL] [Abstract][Full Text] [Related]
36. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
37. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells.
Ramakrishnaiah V; Thumann C; Fofana I; Habersetzer F; Pan Q; de Ruiter PE; Willemsen R; Demmers JA; Stalin Raj V; Jenster G; Kwekkeboom J; Tilanus HW; Haagmans BL; Baumert TF; van der Laan LJ
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13109-13. PubMed ID: 23878230
[TBL] [Abstract][Full Text] [Related]
38. Viral dynamics of persistent hepatitis C virus infection in high-sensitive reporter cells resemble patient's viremia.
Tsai P; Lin CC; Sun HY; Lee JC; Chang TT; Young KC
J Microbiol Immunol Infect; 2018 Aug; 51(4):446-455. PubMed ID: 28698039
[TBL] [Abstract][Full Text] [Related]
39. New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.
Fénéant L; Potel J; François C; Sané F; Douam F; Belouzard S; Calland N; Vausselin T; Rouillé Y; Descamps V; Baumert TF; Duverlie G; Lavillette D; Hober D; Dubuisson J; Wychowski C; Cocquerel L
J Virol; 2015 Aug; 89(16):8346-64. PubMed ID: 26041282
[TBL] [Abstract][Full Text] [Related]
40. A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution.
Tong Y; Li Q; Li R; Xu Y; Pan Y; Niu J; Zhong J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
